SNGX · Soligenix, Inc. · Executive Compensation
$0.35
+0.01 (+3.17%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, as of the date of this filing, the Company continues to explore various strategic alternatives but has not consummated any transaction or obtained any additional program assets to develop which raises substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 7, 2026
Market Cap
$7.48M
Shares
21.77M
Volume · Oct 20
81.15K
Avg daily vol (3M)
222.33K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Christopher J. Schaber | CEO & President | $711,185 |
| Oreola Donini | CSO & Senior VP | $364,242 |
| Jonathan Guarino | CFO & Senior VP | $355,350 |
| Richard Straube | CMO & Senior VP | $242,334 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Christopher J. Schaber | CEO & President | $687,409 |
| Oreola Donini | CSO & Senior VP | $351,079 |
| Jonathan Guarino | CFO & Senior VP | $296,185 |
| Richard Straube | CMO & Senior VP | $225,078 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Christopher J. Schaber | CEO & President | $943,769 |
| Oreola Donini | CSO & Senior VP | $477,949 |
| Richard Straube | CMO & Senior VP | $350,215 |
| Jonathan Guarino | CFO & Senior VP | $349,791 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Christopher J. Schaber | President | $688,149 |
| Oreola Donini | Senior VP | $339,100 |
| Richard Straube | Senior VP | $278,659 |
| Jonathan Guarino | Senior VP | $122,483 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Christopher J. Schaber | President | $618,592 |
| Richard Straube | Senior VP | $431,707 |
| Oreola Donini | Senior VP | $301,838 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard C. Straube, MD | Consulting Chief Medical Officer | Terminated | 2026-06-12 |
| Robert J. Rubin, MD | Director | Appointed | 2025-06-20 |
| Jerome B. Zeldis, MD, PhD | Director | Appointed | 2025-06-20 |
| Diane L. Parks, MBA | Director | Appointed | 2025-06-20 |
| Gregg A. Lapointe, CPA, MBA | Director | Appointed | 2025-06-20 |
| Christopher J. Schaber, PhD | Director | Appointed | 2025-06-20 |
| Timothy R. Coté | member of the Board of Directors | Resigned | 2023-07-07 |
| Timothy R. Coté | director | Appointed | 2023-05-03 |
| Jerome B. Zeldis | director | Appointed | 2022-09-23 |
| Robert J. Rubin | director | Appointed | 2022-09-23 |
| Diane L. Parks | director | Appointed | 2022-09-23 |
| Gregg A. Lapointe | director | Appointed | 2022-09-23 |
| Christopher J. Schaber | director | Appointed | 2022-09-23 |
Leadership
- Christopher J. Schaber CEO, Board Member
- Jonathan Guarino CFO
- Christopher J. Schaber, PhD Board Member
- Diane L. Parks Board Member
- Diane L. Parks, MBA Board Member
- Gregg A. Lapointe Board Member
- Gregg A. Lapointe, CPA, MBA Board Member
- Jerome B. Zeldis Board Member
- Jerome B. Zeldis, MD, PhD Board Member
- Robert J. Rubin Board Member
- Robert J. Rubin, MD Board Member
- Timothy R. Coté Board Member